SEARCH

SEARCH BY CITATION

References

  • Ahmad, N., Feyes, D., Nieminen, A., Agarwal, R. & Mukhtar, H. (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. Journal of the National Cancer Institute, 89, 18811886.
  • Ahmad, N., Gupta, S. & Mukhtar, H. (2000) Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor [kappa]B in cancer cells versus normal cells. Archives of Biochemistry and Biophysics, 376, 338346.
  • Asou, H., Koshizuka, K., Kyo, T., Takata, N., Kamada, N. & Koeffler, H.P. (2002) Resveratrol, a natural product derived from grapes, is a new inducer of differentiation in human myeloid leukemias. International Journal of Hematology, 75, 528533.
  • Bialik, S. & Kimchi, A. (2006) The death-associated protein kinases: structure, function and beyond. Annual Review of Biochemistry, 75, 189210.
  • Britschgi, C., Rizzi, M., Grob, T.J., Tschan, M.P., Hugli, B., Reddy, V.A., Andres, A.-C., Torbett, B.E., Tobler, A. & Fey, M.F. (2005) Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene, 25, 20302039.
  • Britschgi, A., Trinh, E., Rizzi, M., Jenal, M., Ress, A., Tobler, A., Fey, M.F., Helin, K. & Tschan, M.P. (2008) DAPK2 is a novel E2F1//KLF6 target gene involved in their proapoptotic function. Oncogene, 27, 57065716.
  • Chen, Z.P., Schell, J.B., Ho, C.-T. & Chen, K.Y. (1998) Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Letters, 129, 173179.
  • Chow, H.-H.S., Cai, Y., Hakim, I.A., Crowell, J.A., Shahi, F., Brooks, C.A., Dorr, R.T., Hara, Y. & Alberts, D.S. (2003) Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clinical Cancer Research, 9, 33123319.
  • Fang, M.Z., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W. & Yang, C.S. (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Research, 63, 75637570.
  • Feng, W.Y. (2006) Metabolism of green tea catechins: an overview. Current Drug Metabolism, 7, 755809.
  • Gozuacik, D. & Kimchi, A. (2006) DAPk protein family and cancer. Autophagy, 2, 7479.
  • Henning, S.M., Niu, Y., Liu, Y., Lee, N.H., Hara, Y., Thames, G.D., Minutti, R.R., Carpenter, C.L., Wang, H. & Heber, D. (2005) Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. The Journal of Nutritional Biochemistry, 16, 610616.
  • Huo, C., Wan, S.B., Lam, W.H., Li, L., Wang, Z., Landis-Piwowar, K.R., Chen, D., Dou, Q.P. & Chan, T.H. (2008) The challenge of developing green tea polyphenols as therapeutic agents. Inflammopharmacology, 16, 248252.
  • Isbrucker, R.A., Edwards, J.A., Wolz, E., Davidovich, A. & Bausch, J. (2006) Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food and Chemical Toxicology, 44, 636650.
  • Kawasaki, B.T., Hurt, E.M., Mistree, T. & Farrar, W.L. (2008) Targeting cancer stem cells with phytochemicals. Molecular Interventions, 8, 174184.
  • Khan, N. & Mukhtar, H. (2008) Multitargeted therapy of cancer by green tea polyphenols. Cancer Letters, 269, 269280.
  • Khan, N., Afaq, F., Saleem, M., Ahmad, N. & Mukhtar, H. (2006) Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Research, 66, 25002505.
  • Koji, A., Yasushi, M., Daisuke, I., Masako, I., Tsushima, H., Taguchi, J., Fukushima, T., Yoshida, S., Hata, T. & Tomonaga, M. (2008) Expression of 67-Kda Laminin Receptor (67LR) Relates to the Aggressiveness and Poor Prognosis of AML: Modulation of the Expression of GM-CSF Receptor by 67LR. Blood (ASH Annual Meeting Abstracts), 112, 926.
  • Lambert, J.D. & Yang, C.S. (2003) Mechanisms of cancer prevention by tea constituents. Journal of Nutrition, 133, 3262S3267S.
  • Landis-Piwowar, K.R., Milacic, V. & Ping Dou, Q. (2008) Relationship between the methylation status of dietary flavonoids and their growth-inhibitory and apoptosis-inducing activities in human cancer cells. Journal of Cellular Biochemistry, 105, 514523.
  • Lee, Y.K., Bone, N.D., Strege, A.K., Shanafelt, T.D., Jelinek, D.F. & Kay, N.E. (2004) VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood, 104, 788794.
  • Livak, K.J. & Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method. Methods, 25, 402408.
  • Lu, Y.-P., Lou, Y.-R., Xie, J.-G., Peng, Q.-Y., Liao, J., Yang, C.S., Huang, M.-T. & Conney, A.H. (2002) Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proceedings of the National Academy of Sciences of the United States of America, 99, 1245512460.
  • Ménard, S., Castronovo, V., Tagliabue, E. & Sobel, M.E. (1997) New insights into the metastasis-associated 67 kD laminin receptor. Journal of Cellular Biochemistry, 67, 155165.
  • Montuori, N., Selleri, C., Risitano, A.M., Raiola, A.M., Ragno, P., Vecchio, L.D., Rotoli, B. & Rossi, G. (1999) Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation. Clinical Cancer Research, 5, 14651472.
  • Nakagawa, H., Hasumi, K., Woo, J.-T., Nagai, K. & Wachi, M. (2004) Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis, 25, 15671574.
  • Nakazato, T., Ito, K., Miyakawa, Y., Kinjo, K., Yamada, T., Hozumi, N., Ikeda, Y. & Kizaki, M. (2005) Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemic cells via modulation of reactive oxygen species production in vitro and inhibits tumor growth in vivo. Haematologica, 90, 317325.
  • Nakazato, T., Sagawa, M., Yamato, K., Xian, M., Yamamoto, T., Suematsu, M., Ikeda, Y. & Kizaki, M. (2007) Myeloperoxidase is a key regulator of oxidative stress mediated apoptosis in myeloid leukemic cells. Clinical Cancer Research, 13, 54365445.
  • Nasr, R., Guillemin, M.-C., Ferhi, O., Soilihi, H., Peres, L., Berthier, C., Rousselot, P., Robledo-Sarmiento, M., Lallemand-Breitenbach, V., Gourmel, B., Vitoux, D., Pandolfi, P.P., Rochette-Egly, C., Zhu, J. & De The, H. (2008) Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nature Medicine, 14, 13331342.
  • Otsuka, T., Ogo, T., Eto, T., Asano, Y., Suganuma, M. & Niho, Y. (1998) Growth inhibition of leukemic cells by (-)-epigallocatechin gallate, the main constituent of green tea. Life Sciences, 63, 13971403.
  • Rizzi, M., Tschan, M.P., Britschgi, C., Britschgi, A., Hugli, B., Grob, T.J., Leupin, N., Mueller, B.U., Simon, H.-U., Ziemiecki, A., Torbett, B.E., Fey, M.F. & Tobler, A. (2007) The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells. Journal of Leukocyte Biology, 81, 15991608.
  • Sarkar, F.H. & Li, Y. (2006) Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Research, 66, 33473350.
  • Selleri, C., Ragno, P., Ricci, P., Visconte, V., Scarpato, N., Carriero, M.V., Rotoli, B., Rossi, G. & Montuori, N. (2006) The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. Blood, 108, 24762484.
  • Shammas, M.A., Neri, P., Koley, H., Batchu, R.B., Bertheau, R.C., Munshi, V., Prabhala, R., Fulciniti, M., Tai, Y.t., Treon, S.P., Goyal, R.K., Anderson, K.C. & Munshi, N.C. (2006) Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications. Blood, 108, 28042810.
  • Shim, J.-H., Choi, H.S., Pugliese, A., Lee, S.-Y., Chae, J.-I., Choi, B.Y., Bode, A.M. & Dong, Z. (2008) (-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase. Journal of Biological Chemistry, 283, 2837028379.
  • Siddiqui, I., Adhami, V., Bin Hafeez, B., Asim, M., Khwaja, S., Bharali, D., Mousa, S. & Mukhtar, H. (2008) Nanochemoprevention: introducing a novel concept in cancer chemoprevention with a proof of principle for superior activity of green tea polyphenol epigallocatechin-3-gallate encapsulated in PLGA/PVA nanoparticles. Proceedings of the 99th Annual Meeting of the American Association for Cancer Research, 2008, abstract 2102.
  • Surh, Y.-J. (2003) Cancer chemoprevention with dietary phytochemicals. Nature Reviews. Cancer, 3, 768780.
  • Tachibana, H., Koga, K., Fujimura, Y. & Yamada, K. (2004) A receptor for green tea polyphenol EGCG. Nature Structural & Molecular Biology, 11, 380381.
  • Tallman, M.S. (2007) Treatment of relapsed or refractory acute promyelocytic leukemia. Best Practice & Research. Clinical Haematology, 20, 5765.
  • Tschan, M.P., Vonlanthen, S., Cajot, J.F., Peters, U.R., Oppliger, E., Betticher, D.C., Yarbrough, W.G., Fey, M.F. & Tobler, A. (2001) Different p16INK4a and p14ARF expression patterns in acute myeloid leukaemia and normal blood leukocytes. Leukaemia & Lymphoma, 42, 10771087.
  • Umeda, D., Yano, S., Yamada, K. & Tachibana, H. (2008) Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDA laminin receptor. Journal of Biological Chemistry, 283, 30503058.
  • Wang, Z.-Y. & Chen, Z. (2008) Acute promyelocytic leukemia: from highly fatal to highly curable. Blood, 111, 25052515.
  • Wu, K.-M., Ghantous, H. & Birnkrant, D.B. (2008) Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States. Food and Chemical Toxicology, 46, 26062610.
  • Zheng, X., Seshire, A., Ruster, B., Bug, G., Beissert, T., Puccetti, E., Hoelzer, D., Henschler, R. & Ruthardt, M. (2007) Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RAR{alpha}-positive leukemic stem cells. Haematologica, 92, 323331.